Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Performance and Safety of App KidneYou, an Innovative Digital Therapy, in Improving Health of Patients With Chronic Kidney Disease (CKD) by Increasing Their Adherence to Dietary, Exercise Regimens or Mindfulness Program

NCT05286632 is registered in ClinicalTrials.gov with Advice Pharma Group srl as lead sponsor.

NCT NCT05286632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Performance and Safety of App KidneYou, an Innovative Digital Therapy, in Improving Health of Patients With Chronic Kidney Disease (CKD) by Increasing Their Adherence to Dietary, Exercise Regimens or Mindfulness Program
Lead sponsor
Advice Pharma Group srl
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2022
Completion date
July 31, 2024
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, arterial hypertension, chronic glomerulonephritis, chronic kidney diseases, cortical cystic disease, cystic diseases, cystic kidney diseases, diabetes, nephronophthisis, polycystic kidney, treatment adherence, treatment adherence and compliance, tuberous sclerosis